Dl. Tribble et al., FATTY STREAK FORMATION IN FAT-FED MICE EXPRESSING HUMAN COPPER-ZINC SUPEROXIDE-DISMUTASE, Arteriosclerosis, thrombosis, and vascular biology, 17(9), 1997, pp. 1734-1740
Studies in vitro have shown that copper-zinc super-oxide dismutase (Cu
Zn-SOD) inhibits a number of events putatively involved in atherogenes
is, including cell-mediated oxidation of LDL. To investigate whether i
ncreased activity of CuZn-SOD reduces atherogenesis in vivo, we examin
ed diet-induced fatty streak formation in CuZn-SOD transgenic mice (n
= 24) as compared with their nontransgenic littermates (n = 28). Trans
genic animals were originally created by introduction of an EcoRI-BamH
I human genomic DNA fragment containing the CuZn-SOD gene and its regu
latory elements into B6SJL zygotes. For the current studies, the trans
gene was bred for 12 generations into the atherosclerosis-susceptible
C57BL/6 background. Animals were fed atherogenic diets (15% fat, 1.25%
cholesterol, 0.5% Na cholate) starting at 10 weeks of age and extendi
ng for 18 weeks. At the end of the diet period, aortic SOD activity wa
s two-fold higher in transgenics than nontransgenics (mean +/- SE: 46.
7 +/- 5.8 versus 20.1 +/- 2.4 units/mg of protein, P<.001). Levels of
protein-bound amino acid oxidation products (meta-, ortho-, and dityro
sine) were either similar or lower in aorta and heart from transgenics
as compared with nontransgenics, suggesting that amplification of CuZ
n-SOD activity above the normal complement had modest inhibitory effec
ts on basal oxidative stress in these tissues. CuZn-SOD overexpression
did not reduce the extent of lesion development as analyzed by quanti
tative lipid staining of serial sections of the proximal aorta; mean l
esion areas (+/- SE) were 997 +/- 478 and 943 +/- 221 mu(2) in transge
nics and nontransgenics, respectively. Notably, the range of values fo
r lesion area was 2.2-fold greater in transgenics (0-8403 versus 0-386
8 mu(2) in nontransgenics). Moreover, within this group, lesion area s
howed a significant positive correlation with SOD activity (r = .611,
P < .03). These results do not support an antiatherogenic effect of Cu
Zn-SOD over expression, and the possibility that high tissue SOD activ
ity may potentiate atherogenesis in fat-fed atherosclerosis-susceptibl
e mice.